The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 21 May 2001.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Probst-Kepper, M.
Right arrow Articles by Van den Eynde, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Probst-Kepper, M.
Right arrow Articles by Van den Eynde, B. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/2001/5/1189/ $5.00
The Journal of Experimental Medicine, Volume 193, Number 10, May 21, 2001 1189-1198


Original Article

An Alternative Open Reading Frame of the Human Macrophage Colony-stimulating Factor Gene Is Independently Translated and Codes for an Antigenic Peptide of 14 Amino Acids Recognized by Tumor-infiltrating CD8 T Lymphocytes

Michael Probst-Keppera,c, Vincent Stroobanta, Robert Kridela, Béatrice Gauglera, Claire Landrya, Francis Brasseura, Jean-Pierre Cosynsb, Birgit Weynandb, Thierry Boona, and Benoit J. Van den Eyndea
a Ludwig Institute for Cancer Research and Cellular Genetics Unit, Université Catholique de Louvain, Brussels 1200, Belgium
b Department of Pathology, Université Catholique de Louvain, Brussels 1200, Belgium
c Molecular Immunology Group, German Research Centre for Biotechnology, Braunschweig 38124, Germany

Correspondence to: Benoit J. Van den Eynde, Ludwig Institute for Cancer Research and Cellular Genetics Unit, Université Catholique de Louvain 7459, Ave. Hippocrate 74, B-1200 Brussels, Belgium. Tel:32-2-764-7572 Fax:32-2-764-7590 E-mail:benoit.vandeneynde{at}bru.licr.org.

We show that cytotoxic T lymphocytes (CTLs) infiltrating a kidney tumor recognize a peptide encoded by an alternative open reading frame (ORF) of the macrophage colony-stimulating factor (M-CSF) gene. Remarkably, this alternative ORF, which is translated in many tumors concurrently with the major ORF, is also translated in some tissues that do not produce M-CSF, such as liver and kidney. Such a dissociation of the translation of two overlapping ORFs from the same gene is unexpected. The antigenic peptide encoded by the alternative ORF is presented by human histocompatibility leukocyte antigen (HLA)-B*3501 and has a length of 14 residues. Peptide elution indicated that tumor cells naturally present this 14 mer, which is the longest peptide known to be recognized by CTLs. Binding studies of peptide analogues suggest that it binds by its two extremities and bulges out of the HLA groove to compensate for its length.

Key Words: renal cell carcinoma, HLA-B35, translation, peptide binding, natural peptide


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS